Upgrade to SI Premium - Free Trial

Recursion Pharmaceuticals (RXRX) PT Lowered to $5.30 at Morgan Stanley

August 17, 2026 8:58 AM
Morgan Stanley analyst Sean Laaman ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change